Table 2.
Common molecular features observed in expansion diseases.
| Disease | Gene | Expansion | Repeat location | RAN translation-toxicity | RAN translation | RNA toxicity | Loss of function |
|---|---|---|---|---|---|---|---|
| Friedreich’s ataxia | FRDA | GAA/TTC 55–200 | Intron | No | N/A | No | Downregulation of frataxin |
| Myotonic Dystrophy type 1 | DMPK | CTG/CAG 50–1000 | 3’UTR | No | Sense [poly(C), poly(A), poly(L)] Antisense [poly(Q), poly(A), poly(S)] | Yes Recruitment of MBNL1 into RNA foci | Downregulation of MBNL1 and DMPK |
| Myotonic Dystrophy type 2 | CNBP/ZNF9 | CCTG/CAGG 55–11000 | Intron 1 | Yes | Sense [poly(LPAC)] Antisense [poly(QAGR)] | Yes Disbalance of MBNL1 and CUGBP1 and recruitment of MBNL1 into RNA foci | Downregulation of CNBP |
| C9orf72 | C9orf72 | GGGGCC/ GGCCCC 100–4500 | Intron 1 | Yes | Sense [poly (GP), poly(GA), poly (GR)] Antisense [poly (GP), poly (PA), poly (PR)] | Yes Recruitment of RNA binding proteins (hnRNP-H) into RNA foci | Downregulation of C9orf72 |